Latest Insider Transactions at Regeneron Pharmaceuticals, Inc. (REGN)
This section provides a real-time view of insider transactions for Regeneron Pharmaceuticals, Inc. (REGN). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of REGENERON PHARMACEUTICALS, INC. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of REGENERON PHARMACEUTICALS, INC.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
May 07
2021
|
Marion Mc Court EVP Commercial |
BUY
Exercise of conversion of derivative security
|
Direct |
1,000
+5.25%
|
$342,000
$342.93 P/Share
|
|
Apr 01
2021
|
P Roy Vagelos Director |
SELL
Bona fide gift
|
Indirect |
446
-0.31%
|
-
|
|
Feb 25
2021
|
Neil Stahl EVP Research and Development |
SELL
Bona fide gift
|
Direct |
435
-1.76%
|
-
|
|
Feb 23
2021
|
P Roy Vagelos Director |
SELL
Payment of exercise price or tax liability
|
Direct |
137,998
-28.33%
|
$63,203,084
$458.48 P/Share
|
|
Feb 23
2021
|
P Roy Vagelos Director |
BUY
Exercise of conversion of derivative security
|
Direct |
250,000
+17.27%
|
$13,000,000
$52.03 P/Share
|
|
Feb 01
2021
|
Arthur F Ryan Director |
SELL
Open market or private sale
|
Direct |
100
-0.06%
|
$50,700
$507.82 P/Share
|
|
Jan 25
2021
|
Michael S Brown Director |
SELL
Open market or private sale
|
Direct |
2,480
-73.57%
|
$1,373,920
$554.32 P/Share
|
|
Jan 25
2021
|
Michael S Brown Director |
BUY
Exercise of conversion of derivative security
|
Direct |
2,480
+42.39%
|
$942,400
$380.95 P/Share
|
|
Jan 19
2021
|
P Roy Vagelos Director |
SELL
Bona fide gift
|
Indirect |
414
-0.29%
|
-
|
|
Jan 12
2021
|
George Yancopoulos Bd. Co-Chair, President & CSO |
BUY
Bona fide gift
|
Indirect |
82,108
+50.0%
|
-
|
|
Jan 04
2021
|
Joseph L Goldstein Director |
BUY
Grant, award, or other acquisition
|
Direct |
248
+4.04%
|
-
|
|
Jan 04
2021
|
Arthur F Ryan Director |
BUY
Grant, award, or other acquisition
|
Direct |
248
+1.03%
|
-
|
|
Jan 04
2021
|
Arthur F Ryan Director |
SELL
Open market or private sale
|
Direct |
100
-0.03%
|
$48,400
$484.54 P/Share
|
|
Jan 04
2021
|
Bonnie L Bassler Director |
BUY
Grant, award, or other acquisition
|
Direct |
248
+21.77%
|
-
|
|
Jan 04
2021
|
N Anthony Coles Director |
BUY
Grant, award, or other acquisition
|
Direct |
248
+21.57%
|
-
|
|
Jan 04
2021
|
Christine A Poon Director |
BUY
Grant, award, or other acquisition
|
Direct |
248
+12.86%
|
-
|
|
Jan 04
2021
|
Marc Tessier Lavigne Director |
BUY
Grant, award, or other acquisition
|
Direct |
248
+10.66%
|
-
|
|
Jan 04
2021
|
Huda Y Zoghbi Director |
BUY
Grant, award, or other acquisition
|
Direct |
248
+21.77%
|
-
|
|
Jan 04
2021
|
George L Sing Director |
BUY
Grant, award, or other acquisition
|
Direct |
248
+0.45%
|
-
|
|
Jan 04
2021
|
Michael S Brown Director |
BUY
Grant, award, or other acquisition
|
Direct |
248
+21.77%
|
-
|
|
Dec 30
2020
|
George Yancopoulos Bd. Co-Chair, President & CSO |
SELL
Payment of exercise price or tax liability
|
Direct |
216,810
-12.16%
|
$104,719,230
$483.25 P/Share
|
|
Dec 30
2020
|
George Yancopoulos Bd. Co-Chair, President & CSO |
BUY
Exercise of conversion of derivative security
|
Direct |
398,079
+18.12%
|
$20,700,108
$52.03 P/Share
|
|
Dec 09
2020
|
Joseph J Larosa EVP General Counsel and Secret |
BUY
Grant, award, or other acquisition
|
Direct |
1,930
+10.55%
|
-
|
|
Dec 09
2020
|
Robert E Landry EVP Finance CFO |
BUY
Grant, award, or other acquisition
|
Direct |
1,930
+6.93%
|
-
|
|
Dec 09
2020
|
Christopher R. Fenimore SVP Finance & CFO |
BUY
Grant, award, or other acquisition
|
Direct |
2,719
+6.21%
|
-
|
|
Dec 09
2020
|
Neil Stahl EVP Research and Development |
BUY
Grant, award, or other acquisition
|
Direct |
1,688
+6.39%
|
-
|
|
Dec 09
2020
|
Marion Mc Court EVP Commercial |
BUY
Grant, award, or other acquisition
|
Direct |
3,075
+8.59%
|
-
|
|
Dec 09
2020
|
Daniel P Van Plew EVP & General Mgr, Industrial |
BUY
Grant, award, or other acquisition
|
Direct |
6,930
+11.87%
|
-
|
|
Dec 09
2020
|
P Roy Vagelos Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,439
+1.02%
|
-
|
|
Dec 09
2020
|
Andrew J Murphy EVP Research |
BUY
Grant, award, or other acquisition
|
Direct |
10,214
+8.13%
|
-
|
|
Dec 01
2020
|
Arthur F Ryan Director |
SELL
Open market or private sale
|
Direct |
100
-0.04%
|
$51,900
$520.0 P/Share
|
|
Nov 19
2020
|
P Roy Vagelos Director |
BUY
Bona fide gift
|
Indirect |
2,406
+40.0%
|
-
|
|
Nov 19
2020
|
P Roy Vagelos Director |
SELL
Bona fide gift
|
Indirect |
2,406
-4.79%
|
-
|
|
Nov 17
2020
|
Andrew J Murphy EVP Research |
SELL
Open market or private sale
|
Direct |
6,628
-0.69%
|
$3,612,260
$545.61 P/Share
|
|
Nov 16
2020
|
Andrew J Murphy EVP Research |
SELL
Payment of exercise price or tax liability
|
Direct |
7,108
-11.68%
|
$3,987,588
$561.39 P/Share
|
|
Nov 16
2020
|
Andrew J Murphy EVP Research |
BUY
Exercise of conversion of derivative security
|
Direct |
13,736
+18.41%
|
$412,080
$30.63 P/Share
|
|
Nov 13
2020
|
N Anthony Coles Director |
BUY
Exercise of conversion of derivative security
|
Direct |
11
+1.65%
|
$3,795
$345.47 P/Share
|
|
Nov 02
2020
|
Arthur F Ryan Director |
SELL
Open market or private sale
|
Direct |
100
-0.07%
|
$54,800
$548.92 P/Share
|
|
Oct 22
2020
|
Andrew J Murphy EVP Research |
BUY
Exercise of conversion of derivative security
|
Direct |
5,185
+5.34%
|
$212,585
$41.33 P/Share
|
|
Oct 06
2020
|
P Roy Vagelos Director |
SELL
Bona fide gift
|
Indirect |
349
-0.24%
|
-
|
|
Oct 05
2020
|
Joseph L Goldstein Director |
SELL
Open market or private sale
|
Direct |
9,212
-62.01%
|
$5,527,200
$600.0 P/Share
|
|
Oct 05
2020
|
Joseph L Goldstein Director |
BUY
Exercise of conversion of derivative security
|
Direct |
9,212
+38.28%
|
$4,790,240
$520.01 P/Share
|
|
Oct 05
2020
|
Marion Mc Court EVP Commercial |
SELL
Open market or private sale
|
Direct |
1,000
-6.68%
|
$600,000
$600.0 P/Share
|
|
Oct 05
2020
|
Marion Mc Court EVP Commercial |
BUY
Exercise of conversion of derivative security
|
Direct |
1,000
+6.26%
|
$342,000
$342.93 P/Share
|
|
Oct 01
2020
|
Arthur F Ryan Director |
SELL
Open market or private sale
|
Direct |
100
-0.03%
|
$55,900
$559.51 P/Share
|
|
Sep 24
2020
|
Christopher R. Fenimore SVP Finance & CFO |
BUY
Bona fide gift
|
Indirect |
50
+50.0%
|
-
|
|
Sep 24
2020
|
Christopher R. Fenimore SVP Finance & CFO |
SELL
Bona fide gift
|
Indirect |
50
-100.0%
|
-
|
|
Aug 20
2020
|
Marion Mc Court EVP Commercial |
SELL
Open market or private sale
|
Direct |
1,000
-6.68%
|
$612,000
$612.15 P/Share
|
|
Aug 20
2020
|
Marion Mc Court EVP Commercial |
BUY
Exercise of conversion of derivative security
|
Direct |
1,000
+6.26%
|
$342,000
$342.93 P/Share
|
|
Jul 27
2020
|
George Yancopoulos Bd. Co-Chair, President & CSO |
SELL
Bona fide gift
|
Indirect |
57,465
-100.0%
|
-
|